Filters close

Not for public release

This news release is embargoed until 10-Jun-2024 5:00 PM EDT Released to reporters: 4-Jun-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-Jun-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 10-Jun-2024 5:00 PM EDT Released to reporters: 4-Jun-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-Jun-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 10-Jun-2024 5:00 PM EDT Released to reporters: 4-Jun-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-Jun-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 13-Jun-2024 8:00 AM EDT Release date to reporters: 10-Jun-2024 4:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-Jun-2024 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Replacing Registered Nurses in High Stakes Hospital Care 
is Dangerous to Patients
Release date: 10-Jun-2024 3:30 PM EDT
Replacing Registered Nurses in High Stakes Hospital Care is Dangerous to Patients
University of Pennsylvania School of Nursing

A new study published in Medical Care today showed that substituting registered nurses (RN) with lower-wage staff (e.g. licensed practical nurses, unlicensed assistive personnel) in hospital care is linked with more deaths, readmissions, longer hospital stays, poorer patient satisfaction, and higher costs of care.

UNREVIEWED

Newswise: Engaging With Patients for Better Treatments and Outcomes for Smell and Taste Disorders
Release date: 10-Jun-2024 3:05 PM EDT
Engaging With Patients for Better Treatments and Outcomes for Smell and Taste Disorders
Monell Chemical Senses Center

in 2022 collaborators - patient groups, basic researchers, and clinicians - conducted a survey and listening sessions with patients, caregivers, and family members affected by impaired smell or taste. They asked about their individual perceptions of the effectiveness of treatments, among other topics. Using an online questionnaire, over 5,800 people in the U.S. - from all 50 states and the District of Columbia - answered the team’s call to action. The findings underscore the importance of conducting more large-scale, randomized clinical trials that include older participant, as well as how enthusiastic and involve patients would like to be

UNREVIEWED

Release date: 10-Jun-2024 3:05 PM EDT
UC Davis total-body advanced PET scanner EXPLORER can visualize dual blood supply in lung cancer
UC Davis Health

New study shows UC Davis total-body advanced PET scanner EXPLORER can visualize dual blood supply in lungs and effectively evaluate lung cancer and track treatment progress.

UNREVIEWED

Newswise: UC San Diego Develops First-In-Kind Protocol for Creating ‘Wired Miniature Brains’
Release date: 10-Jun-2024 3:00 PM EDT
UC San Diego Develops First-In-Kind Protocol for Creating ‘Wired Miniature Brains’
University of California San Diego

Researchers have developed — and shared — a process for creating brain cortical organoids — essentially miniature artificial brains with functioning neural networks

UNREVIEWED

Newswise: 227209.jpg
Release date: 10-Jun-2024 2:05 PM EDT
New Study Shows State of Illinois a Leader in Legislation on Perinatal Mental Health
School of Social Work, University of Illinois Urbana-Champaign

Having advanced six policies since 2008 to detect and promote treatment of perinatal mental health conditions, the state of Illinois has emerged as a leader in these critical health areas, according to a study by University of Illinois Urbana-Champaign social work professors Karen M. Tabb, center, and Sandra Kopels. U. of I. alumnus Xavier Ramirez co-wrote the paper, published in Frontiers in Psychiatry.

UNREVIEWED

Released: 10-Jun-2024 1:30 PM EDT
Hevolution Foundation: Transforming Healthspan Science with Unprecedented $400M Funding Surge
Hevolution Foundation

Hevolution Foundation, a global nonprofit organization that provides grants and early-stage investments to incentivize research and entrepreneurship in healthspan science, has committed over $400 million to healthspan sciences within the past 21 months, positioning the Foundation as the world's largest philanthropic funder of geroscience.

   
Release date: 10-Jun-2024 1:05 PM EDT
Does Your Child Need Travel Vaccines Before an International Trip?
Children's Hospital Los Angeles

If you’re planning an international trip with your child, you may be wondering what vaccines they need and when they should get them. Before you head out of the country, it’s essential to make sure your child is up to date on all of their routine immunizations, including vaccines for COVID-19, flu and RSV. But what additional vaccines should they get? The answer depends on your child’s age and where you’re going.

UNREVIEWED

Newswise: 1920_aging-alzheimers-cedars-sinai.jpg?10000
Release date: 10-Jun-2024 1:05 PM EDT
Reducing the Risk for Alzheimer’s Disease
Cedars-Sinai

Cedars-Sinai has launched a program to help people 40 and older who do not have Alzheimer’s disease but want to understand—and reduce—their risk for developing the illness.

UNREVIEWED

Newswise: termhub_green_gray_large_Log
Release date: 10-Jun-2024 1:05 PM EDT
TermHub Now Supports USCDI Version 4: Revolutionizing Digital Healthcare Terminology Management
West Coast Informatics, Inc

TermHub, the cloud-based healthcare terminology management system, is proud to announce that it now fully supports all content mandated in the latest version of the United States Core Data for Interoperability (USCDI), specifically USCDI Version 4.

UNREVIEWED

   
Newswise: Unregulated Sales of a Toxic and Hallucinogenic Mushroom Endanger Public Health
Release date: 10-Jun-2024 12:05 PM EDT
Unregulated Sales of a Toxic and Hallucinogenic Mushroom Endanger Public Health
University of California San Diego

Americans' interest in a potentially harmful "magic mushroom" is soaring, according to a new study by researchers at the University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science. The scientists suggest that the growing market for Amanita muscaria may be sparked in part by emerging clinical research supporting the safety and efficacy of psilocybin as a treatment for depression.

UNREVIEWED

Release date: 10-Jun-2024 11:15 AM EDT
Ochsner Medical Center welcomes latest da Vinci robotic surgical system
Ochsner Health

The da Vinci 5’s biggest innovation is enabling the surgeon’s hands to feel the same amount of pressure used by the robotic instruments.

UNREVIEWED

Newswise: Intervention Aims to Improve Cardiovascular Health for South Asian Populations
Release date: 10-Jun-2024 11:05 AM EDT
Intervention Aims to Improve Cardiovascular Health for South Asian Populations
University of Utah Health

People from South Asian countries tend to develop heart disease 10 years earlier than other populations. Kevin Shah, MD, is working to change that.

UNREVIEWED

Release date: 10-Jun-2024 11:05 AM EDT
‘Cutting the cable’ between CD8+ T and T regulatory cells enhances checkpoint immunotherapy
University of California, Irvine

Checkpoint immunotherapy utilizing PD-1 blockade has become the standard of care for metastatic melanoma. While this treatment is effective in 40 percent of patients, the other 60 percent develop resistance, leading to tumor regrowth. A multidisciplinary research team led by the University of California, Irvine has identified a new strategy that could enhance the therapeutic effectiveness of this therapy by targeting the communication between immune cells within the tumor.

UNREVIEWED

Newswise: Super-Chilled Brain Cell Molecules Reveal How Epilepsy Drug Works
Released: 10-Jun-2024 11:00 AM EDT
Super-Chilled Brain Cell Molecules Reveal How Epilepsy Drug Works
Johns Hopkins Medicine

By super cooling a molecule on the surface of brain cells down to about minus 180 degrees Celsius — nearly twice as cold as the coldest places in Antarctica — scientists at Johns Hopkins Medicine say they have determined how a widely-used epilepsy drug works to dampen the excitability of brain cells and help to control, although not cure, seizures.

Newswise: New Study Finds Most Eligible U.S. Adults not Getting Screened for Lung Cancer
5-Jun-2024 11:05 PM EDT
New Study Finds Most Eligible U.S. Adults not Getting Screened for Lung Cancer
American Cancer Society (ACS)

A new study led by American Cancer Society researchers shows less than one-in-five eligible individuals in the United States were up-to-date with recommended lung cancer screening. The screening uptake was much lower in persons without health insurance or usual source of care and in Southern states with the highest lung cancer burden.

Newswise: Multicenter clinical study supports safety of deep general anesthesia
5-Jun-2024 3:05 PM EDT
Multicenter clinical study supports safety of deep general anesthesia
Washington University in St. Louis

New research from Washington University School of Medicine in St. Louis and other institutions supports earlier findings that indicate that anesthesia is no more hazardous for the brain at higher doses than at lower doses.

Released: 10-Jun-2024 10:30 AM EDT
Treating nephrocalcinosis in newborns: A primer for clinicians
UC Davis Health

As many as 40% of preterm infants in the U.S. suffer from nephrocalcinosis, a condition that deposits excess calcium in kidneys.

access_time Embargo lifts in 2 days
This news release is embargoed until 12-Jun-2024 11:00 AM EDT Released to reporters: 10-Jun-2024 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Study links chronic pain to quality of family relationships
Released: 10-Jun-2024 10:05 AM EDT
Study links chronic pain to quality of family relationships
UT Southwestern Medical Center

Strong family relationships have long been associated with a better sense of well-being and connection. Now a team led by UT Southwestern Medical Center researchers has linked the quality of those relationships with how successfully people – particularly aging African Americans – manage pain.

access_time Embargo lifts in 2 days
This news release is embargoed until 12-Jun-2024 2:00 PM EDT Released to reporters: 10-Jun-2024 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2024 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 10-Jun-2024 9:05 AM EDT
FASEB Conferences On-Demand Streams Scientific Breakthroughs
Federation of American Societies for Experimental Biology (FASEB)

The Federation of American Societies for Experimental Biology (FASEB) launches a new service to stream the latest content from in-person FASEB Science Research Conferences.

   
Released: 10-Jun-2024 9:00 AM EDT
Icahn School of Medicine at Mount Sinai Awarded $21 Million NIH Grant to Advance Understanding of Aging-Related Hormone
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a $21 million grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH), to further advance understanding of an aging-related hormone known as follicle-stimulating hormone (FSH), including its potential role in obesity, osteoporosis, and Alzheimer’s disease.

access_time Embargo lifts in 2 days
This news release is embargoed until 11-Jun-2024 4:00 PM EDT Released to reporters: 10-Jun-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-Jun-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 10-Jun-2024 9:00 AM EDT
NUTRITION 2024 showcases groundbreaking research on what we eat and why it matters
American Society for Nutrition (ASN)

Be among the first to hear breaking news in food and nutrition science at NUTRITION 2024, the annual flagship meeting of the American Society for Nutrition held June 29–July 2 at McCormick Place in Chicago.

Newswise: Clinical trial shows promising results in a two-drug combination that curbs methamphetamine use
7-Jun-2024 5:05 PM EDT
Clinical trial shows promising results in a two-drug combination that curbs methamphetamine use
University of California, Los Angeles (UCLA), Health Sciences

A clinical trial on a two-drug therapy for methamphetamine use disorder reduced use of the highly addictive drug for up to 12 weeks after initiation of treatment. To date there is no FDA-approved medication for it.

Released: 10-Jun-2024 7:30 AM EDT
Timely response leads to complete recovery for young stroke survivor
Michigan Medicine - University of Michigan

Fewer than 15% of patients make it to a hospital in time to receive the most advanced stroke treatments.

Newswise: Valentin Fuster, MD, PhD, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)
Release date: 10-Jun-2024 7:00 AM EDT
Valentin Fuster, MD, PhD, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)
Mount Sinai Health System

President of Mount Sinai Fuster Heart Hospital given top honor for his scientific excellence and successful global education initiatives on cardiovascular disease

UNREVIEWED

Not for public release

This news release is embargoed until 12-Jun-2024 9:00 AM EDT Released to reporters: 10-Jun-2024 5:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2024 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

   
access_time Embargo lifts in 2 days
This news release is embargoed until 11-Jun-2024 5:00 AM EDT Released to reporters: 10-Jun-2024 5:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-Jun-2024 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 23-Jun-2024 9:00 AM EDT Released to reporters: 9-Jun-2024 8:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Jun-2024 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

     
access_time Embargo lifts in 2 days
This news release is embargoed until 12-Jun-2024 2:00 PM EDT Released to reporters: 9-Jun-2024 7:30 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2024 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

   
access_time Embargo lifts in 2 days
This news release is embargoed until 23-Jun-2024 8:00 AM EDT Released to reporters: 9-Jun-2024 7:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Jun-2024 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

     
access_time Embargo lifts in 2 days
This news release is embargoed until 23-Jun-2024 8:00 AM EDT Released to reporters: 9-Jun-2024 7:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Jun-2024 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

     
Newswise: Texas Tech Health El Paso, UTEP Announce New MedFuture Cohort, Part of Our Region’s Next Generation of Physicians
Released: 7-Jun-2024 4:30 PM EDT
Texas Tech Health El Paso, UTEP Announce New MedFuture Cohort, Part of Our Region’s Next Generation of Physicians
Texas Tech University Health Sciences Center El Paso

Adolpho and Debbie Telles announce a $50,000 gift for the Adolpho R. and Deborah L. Telles Family Scholarship, which will be matched by the KPMG Foundation to double its impact to $100,000.

access_time Embargo lifts in 2 days
This news release is embargoed until 12-Jun-2024 11:00 AM EDT Released to reporters: 7-Jun-2024 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Letter to editor and response: Is neurocysticercosis a main cause of epilepsy?
Released: 7-Jun-2024 12:05 PM EDT
Letter to editor and response: Is neurocysticercosis a main cause of epilepsy?
International League Against Epilepsy

ILAE produced a podcast episode in 2023 in which Dr. Hector Garcia talked about neurocysticercosis as a main cause of epilepsy. Two researchers from Latin America wrote in and questioned how frequently this parasitic infection actually leads to epilepsy. Dr. Garcia responded.

Newswise: Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
Released: 7-Jun-2024 11:45 AM EDT
Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center has earned its most highly rated grant from the National Cancer Institute (NCI). The NCI renewed Roswell Park’s status as a Comprehensive Cancer Center - a designation held by less than 4% of cancer centers- awarding Roswell Park the highest possible “Exceptional” rating as it renewed a grant Roswell Park has successfully competed for since 1972.

access_time Embargo lifts in 2 days
This news release is embargoed until 12-Jun-2024 4:00 PM EDT Released to reporters: 7-Jun-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 12-Jun-2024 4:00 PM EDT Released to reporters: 7-Jun-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Fat Molecule’s Inability to Bond with Shape-Shifting Protein in Cell’s Powerhouse Linked to an Inherited Metabolic Disease
Released: 7-Jun-2024 11:00 AM EDT
Fat Molecule’s Inability to Bond with Shape-Shifting Protein in Cell’s Powerhouse Linked to an Inherited Metabolic Disease
Johns Hopkins Medicine

By studying mutations in yeast and human cells, Johns Hopkins Medicine scientists say they have found that biochemical bonds between fats and proteins in the mitochondrion, the cell’s powerhouse, play a crucial role in how our cells produce energy.

access_time Embargo lifts in 2 days
This news release is embargoed until 12-Jun-2024 5:00 PM EDT Released to reporters: 7-Jun-2024 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.



close
0.21023